BioInvent International AB (BINV) — Financial Flexibility Index
BioInvent International AB (BINV) has a Financial Flexibility Index of 0.64x as of June 2025. Free cash flow of Skr68.16 Million (operating CF Skr66.78 Million minus capex Skr1.38 Million) represents 1% of total liabilities (Skr105.93 Million). Check BINV capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioInvent International AB Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for BioInvent International AB across 23 annual periods. For the full cash flow conversion analysis, see BINV cash flow conversion.
Annual Financial Flexibility Index for BioInvent International AB (2002–2024)
Year-by-year free cash flow to debt coverage for BioInvent International AB. Explore BioInvent International AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.58x | Skr-370.44 Million | Skr-380.47 Million | Skr103.42 Million | ▲ +1.3% |
| 2023 | -3.63x | Skr-328.39 Million | Skr-341.69 Million | Skr90.45 Million | ▼ -1235.1% |
| 2022 | -0.27x | Skr-28.85 Million | Skr-41.23 Million | Skr106.09 Million | ▲ +90.6% |
| 2021 | -2.90x | Skr-232.58 Million | Skr-245.84 Million | Skr80.32 Million | ▼ -206.2% |
| 2020 | -0.95x | Skr-55.92 Million | Skr-62.62 Million | Skr59.14 Million | ▲ +55.9% |
| 2019 | -2.15x | Skr-121.59 Million | Skr-125.43 Million | Skr56.67 Million | ▲ +48.9% |
| 2018 | -4.20x | Skr-137.55 Million | Skr-141.39 Million | Skr32.78 Million | ▼ -181.3% |
| 2017 | -1.49x | Skr-59.40 Million | Skr-75.88 Million | Skr39.82 Million | ▼ -2.5% |
| 2016 | -1.45x | Skr-66.73 Million | Skr-72.05 Million | Skr45.86 Million | ▲ +49.4% |
| 2015 | -2.88x | Skr-71.90 Million | Skr-72.57 Million | Skr24.99 Million | ▲ +17.5% |
| 2014 | -3.49x | Skr-75.61 Million | Skr-76.03 Million | Skr21.68 Million | ▼ -107.1% |
| 2013 | -1.68x | Skr-54.60 Million | Skr-54.65 Million | Skr32.43 Million | ▲ +31.9% |
| 2012 | -2.47x | Skr-170.32 Million | Skr-170.38 Million | Skr68.92 Million | ▼ -231.6% |
| 2011 | -0.75x | Skr-50.54 Million | Skr-55.45 Million | Skr67.81 Million | ▲ +57.9% |
| 2010 | -1.77x | Skr-113.07 Million | Skr-117.70 Million | Skr63.84 Million | ▲ +0.6% |
| 2009 | -1.78x | Skr-125.85 Million | Skr-127.14 Million | Skr70.61 Million | ▼ -299.2% |
| 2008 | 0.89x | Skr57.37 Million | Skr43.73 Million | Skr64.13 Million | ▲ +207.7% |
| 2007 | 0.29x | Skr16.54 Million | Skr12.63 Million | Skr56.88 Million | ▲ +112.0% |
| 2006 | -2.42x | Skr-92.27 Million | Skr-101.23 Million | Skr38.18 Million | ▼ -39.3% |
| 2005 | -1.73x | Skr-82.11 Million | Skr-105.48 Million | Skr47.34 Million | ▲ +46.4% |
| 2004 | -3.23x | Skr-83.18 Million | Skr-88.74 Million | Skr25.73 Million | ▼ -116.8% |
| 2003 | -1.49x | Skr-57.02 Million | Skr-66.25 Million | Skr38.23 Million | ▼ -399.9% |
| 2002 | 0.50x | Skr25.94 Million | Skr-10.57 Million | Skr52.16 Million | — |